Homologous or heterogenous vaccination boosters enhance neutralizing activities against SARS-CoV-2 Omicron BA.1 variant同源或异源疫苗接种增强剂可增强针对SARS-CoV-2 Omicron BA.1变体的中和活性MEDCOMMIF10.72022-05-114OAAI